|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 203.87 USD | -2.20% |
|
-2.75% | -15.36% |
| 07:48am | Citi Downgrades ResMed to Neutral From Buy; Price Target is AU$34 | MT |
| 07-10 | Jefferies Adjusts Price Target on ResMed to $225 From $240 | MT |
Insider Transaction History
Latest insider transactions for ResMed, Inc.
| Date | Insider | Type | Main position | Quantity | Price | Amount | % Market Cap. | |
|---|---|---|---|---|---|---|---|---|
| 07-06 | Fiscal year | Chief Executive Officer | 14,973 | 182.44 | 1.82M | 0.0103% | ||
| 06-07 | Fiscal year | Chief Executive Officer | 14,973 | 170.15 | 1.7M | 0.0103% | ||
| 05-31 | Tax | General Counsel | -269 | 190.57 | - | 0.0002% | ||
| 05-06 | Fiscal year | Chief Executive Officer | 14,973 | 177.08 | 1.77M | 0.0103% | ||
| 05-03 | Other | Chief Financial Officer | 0 | 207.88 | - | 0% | ||
| 04-06 | Fiscal year | Chief Executive Officer | 14,973 | 185.92 | 1.86M | 0.0103% | ||
| 03-31 | Sell | Founder | 2,000 | 225.00 | 450K | 0.0014% | ||
| 03-31 | Sell | Chief Financial Officer | 1,000 | 224.31 | 224K | 0.0007% | ||
| 03-08 | Fiscal year | Chief Executive Officer | 14,973 | 198.68 | 1.98M | 0.0103% | ||
| 03-03 | Sell | Founder | 2,000 | 260.22 | 520K | 0.0014% | ||
| 03-01 | Sell | Chief Financial Officer | 1,000 | 254.30 | 254K | 0.0007% | ||
| 02-08 | Fiscal year | Chief Executive Officer | 14,973 | 210.06 | 2.1M | 0.0103% | ||
| 02-03 | Sell | General Counsel | 50 | 260.00 | 13K | 0.0000% | ||
| 02-03 | Sell | Founder | 2,000 | 251.31 | 503K | 0.0014% | ||
| 02-01 | Sell | Chief Financial Officer | 1,000 | 257.03 | 257K | 0.0007% | ||
| 01-06 | Fiscal year | Chief Executive Officer | 14,973 | 197.40 | 1.97M | 0.0103% | ||
| 01-06 | Sell | Founder | 2,000 | 248.83 | 498K | 0.0014% | ||
| 01-01 | Sell | Chief Financial Officer | 1,000 | 241.75 | 242K | 0.0007% | ||
| 01-01 | Sell | General Counsel | 50 | 241.75 | 12.09K | 0.0000% | ||
| 12-07 | Fiscal year | Chief Executive Officer | 14,973 | 198.88 | 1.99M | 0.0103% | ||
| 12-02 | Sell | Founder | 2,000 | 251.47 | 503K | 0.0014% | ||
| 11-30 | Sell | Chief Financial Officer | 1,000 | 244.16 | 244K | 0.0007% | ||
| 11-30 | Sell | General Counsel | 50 | 244.16 | 12.21K | 0.0000% | ||
| 11-24 | Sell | Director | 2,055 | 255.00 | 524K | 0.0014% | ||
| 11-23 | Other | Director | 1,331 | - | - | 0.0009% | ||
| 11-23 | Other | Founder | 1,331 | - | - | 0.0009% | ||
| 11-23 | Other | Chief Executive Officer | 33,288 | - | - | 0.0228% | ||
| 11-19 | Free | Executive/Senior Manager | 1,848 | - | - | 0.0013% | ||
| 11-19 | Free | Director | 1,073 | - | - | 0.0007% | ||
| 11-19 | Free | Chief Financial Officer | 2,710 | - | - | 0.0019% | ||
| 11-19 | Free | Director | 1,073 | - | - | 0.0007% | ||
| 11-19 | Free | Director | 536 | - | - | 0.0004% | ||
| 11-19 | Free | Chief Executive Officer | 20,848 | - | - | 0.0143% | ||
| 11-19 | Free | Founder | 536 | - | - | 0.0004% | ||
| 11-19 | Free | Director | 1,073 | - | - | 0.0007% | ||
| 11-19 | Free | Director | 1,073 | - | - | 0.0007% | ||
| 11-19 | Free | Director | 1,073 | - | - | 0.0007% | ||
| 11-19 | Free | Director | 1,073 | - | - | 0.0007% | ||
| 11-19 | Free | Director | 1,073 | - | - | 0.0007% | ||
| 11-19 | Free | Director | 1,073 | - | - | 0.0007% | ||
| 11-18 | Other | Director | 0 | - | - | 0% | ||
| 11-13 | Fiscal year | Founder | 30,198 | 157.33 | 2.95M | 0.0207% | ||
| 11-10 | Tax | Director | 38 | 250.10 | 9.5K | 0.0000% | ||
| 11-10 | Tax | Founder | 2,163 | 251.90 | 545K | 0.0015% | ||
| 11-10 | Tax | General Counsel | 1,525 | 250.10 | 381K | 0.0010% | ||
| 11-10 | Tax | Chief Executive Officer | 7,897 | 250.10 | 1.98M | 0.0054% | ||
| 11-10 | Sell | Director | 563 | 250.23 | 141K | 0.0004% | ||
| 11-06 | Fiscal year | Chief Executive Officer | 24,033 | 175.70 | 2.81M | 0.0165% | ||
| 11-02 | Fiscal year | Chief Financial Officer | 7,000 | 189.18 | 946K | 0.0048% | ||
| 06/10/25 | Fiscal year | Chief Executive Officer | 24,027 | 192.24 | 3.08M | 0.0164% | ||
- Stock Market
- Stocks
- RMD Stock
- Company ResMed, Inc.
- Insider transactions
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition















